Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2021 | Apr. 30, 2021 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2021 | |
Document Transition Report | false | |
Entity File Number | 001-36773 | |
Entity Registrant Name | WORKIVA INC | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 47-2509828 | |
Entity Address, Address Line One | 2900 University Blvd | |
Entity Address, City or Town | Ames | |
Entity Address, State or Province | IA | |
Entity Address, Postal Zip Code | 50010 | |
City Area Code | 888 | |
Local Phone Number | 275-3125 | |
Title of 12(b) Security | Class A common stock, par value $.001 | |
Trading Symbol | WK | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Central Index Key | 0001445305 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2021 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Class A Common Stock | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 42,209,295 | |
Class B Common Stock | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 7,784,610 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Current assets | ||
Cash and cash equivalents | $ 331,173 | $ 322,831 |
Marketable securities | 209,446 | 207,207 |
Accounts receivable, net of allowance for doubtful accounts of $599 and $717 at March 31, 2021 and December 31, 2020, respectively | 53,754 | 68,922 |
Deferred commissions | 22,924 | 21,923 |
Other receivables | 3,314 | 3,155 |
Prepaid expenses and other | 12,758 | 9,047 |
Total current assets | 633,369 | 633,085 |
Property and equipment, net | 28,961 | 29,365 |
Operating lease right-of-use assets | 16,501 | 15,844 |
Deferred commissions, non-current | 23,422 | 23,421 |
Intangible assets, net | 1,560 | 1,583 |
Other assets | 4,610 | 3,708 |
Total assets | 708,423 | 707,006 |
Current liabilities | ||
Accounts payable | 4,716 | 2,843 |
Accrued expenses and other current liabilities | 60,110 | 68,256 |
Deferred revenue | 212,025 | 208,990 |
Finance lease obligations | 1,728 | 1,705 |
Total current liabilities | 278,579 | 281,794 |
Convertible senior notes, net | 291,756 | 289,490 |
Deferred revenue, non-current | 32,888 | 35,894 |
Other long-term liabilities | 1,683 | 1,680 |
Operating lease liabilities, non-current | 17,540 | 17,209 |
Finance lease obligations, non-current | 16,221 | 16,662 |
Total liabilities | 638,667 | 642,729 |
Stockholders’ equity | ||
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding | 0 | 0 |
Additional paid-in-capital | 491,549 | 478,698 |
Accumulated deficit | (422,024) | (414,700) |
Accumulated other comprehensive income | 181 | 230 |
Total stockholders’ equity | 69,756 | 64,277 |
Total liabilities and stockholders’ equity | 708,423 | 707,006 |
Class A Common Stock | ||
Stockholders’ equity | ||
Common stock | 42 | 41 |
Class B Common Stock | ||
Stockholders’ equity | ||
Common stock | $ 8 | $ 8 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Allowance for doubtful accounts | $ 599 | $ 717 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 100,000,000 | 100,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Class A Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, share authorized | 1,000,000,000 | 1,000,000,000 |
Common stock, shares issued | 42,102,011 | 40,719,189 |
Common stock, shares outstanding | 42,102,011 | 40,719,189 |
Class B Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, share authorized | 500,000,000 | 500,000,000 |
Common stock, shares issued | 7,824,610 | 8,069,610 |
Common stock, shares outstanding | 7,824,610 | 8,069,610 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Revenue | ||
Total revenue | $ 104,222 | $ 85,801 |
Cost of revenue | ||
Total cost of revenue | 23,676 | 22,396 |
Gross profit | 80,546 | 63,405 |
Operating expenses | ||
Research and development | 26,634 | 22,994 |
Sales and marketing | 41,035 | 36,117 |
General and administrative | 17,021 | 13,369 |
Total operating expenses | 84,690 | 72,480 |
Loss from operations | (4,144) | (9,075) |
Interest income | 360 | 1,706 |
Interest expense | (3,485) | (3,478) |
Other (expense) income, net | (384) | 718 |
Loss before (benefit) provision for income taxes | (7,653) | (10,129) |
(Benefit) provision for income taxes | (329) | 289 |
Net loss | $ (7,324) | $ (10,418) |
Net loss per common share: | ||
Basic (in dollars per share) | $ (0.15) | $ (0.22) |
Diluted (in dollars per share) | $ (0.15) | $ (0.22) |
Weighted-average common shares outstanding - basic | 50,244,120 | 47,545,703 |
Weighted-average common shares outstanding - diluted | 50,244,120 | 47,545,703 |
Subscription and support | ||
Revenue | ||
Total revenue | $ 84,936 | $ 68,361 |
Cost of revenue | ||
Total cost of revenue | 13,202 | 12,153 |
Professional services | ||
Revenue | ||
Total revenue | 19,286 | 17,440 |
Cost of revenue | ||
Total cost of revenue | $ 10,474 | $ 10,243 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Statement of Comprehensive Income [Abstract] | ||
Net loss | $ (7,324) | $ (10,418) |
Other comprehensive loss, net of tax | ||
Foreign currency translation adjustment, net of tax | 156 | (51) |
Unrealized (loss) gain on available-for-sale securities, net of tax | (205) | 42 |
Other comprehensive loss, net of tax | (49) | (9) |
Comprehensive loss | $ (7,373) | $ (10,427) |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Common Stock (Class A and B) | Additional Paid-in-Capital | Accumulated Other Comprehensive Income | Accumulated Deficit |
Shares, Outstanding, Beginning at Dec. 31, 2019 | 46,639,000 | ||||
Beginning of the period at Dec. 31, 2019 | $ 54,202 | $ 47 | $ 420,170 | $ 287 | $ (366,302) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation expense | 9,936 | 9,936 | |||
Issuance of common stock upon exercise of stock options (in shares) | 225,000 | ||||
Issuance of common stock upon exercise of stock options | 2,794 | 2,794 | |||
Issuance of common stock under employee stock purchase plan (in shares) | 94,000 | ||||
Issuance of common stock under employee stock purchase plan | 3,660 | 3,660 | |||
Issuance of restricted stock units (in shares) | 117,000 | ||||
Tax withholding related to net share settlements of stock-based compensation awards (in shares) | (30,000) | ||||
Tax withholding related to net share settlements of stock-based compensation awards | (1,379) | (1,379) | |||
Net loss | (10,418) | (10,418) | |||
Other comprehensive loss | (9) | (9) | |||
End of period at Mar. 31, 2020 | 58,786 | $ 47 | 435,181 | 278 | (376,720) |
Shares, Outstanding, Ending at Mar. 31, 2020 | 47,045,000 | ||||
Shares, Outstanding, Beginning at Dec. 31, 2020 | 48,789,000 | ||||
Beginning of the period at Dec. 31, 2020 | 64,277 | $ 49 | 478,698 | 230 | (414,700) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation expense | $ 11,623 | 11,623 | |||
Issuance of common stock upon exercise of stock options (in shares) | 312,352 | 312,000 | |||
Issuance of common stock upon exercise of stock options | $ 4,138 | $ 1 | 4,137 | ||
Issuance of common stock under employee stock purchase plan (in shares) | 93,000 | ||||
Issuance of common stock under employee stock purchase plan | 4,237 | 4,237 | |||
Issuance of restricted stock units (in shares) | 803,000 | ||||
Tax withholding related to net share settlements of stock-based compensation awards (in shares) | (70,000) | ||||
Tax withholding related to net share settlements of stock-based compensation awards | (7,146) | (7,146) | |||
Net loss | (7,324) | (7,324) | |||
Other comprehensive loss | (49) | (49) | |||
End of period at Mar. 31, 2021 | $ 69,756 | $ 50 | $ 491,549 | $ 181 | $ (422,024) |
Shares, Outstanding, Ending at Mar. 31, 2021 | 49,927,000 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Cash flows from operating activities | ||
Net loss | $ (7,324) | $ (10,418) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 1,054 | 1,063 |
Stock-based compensation expense | 11,623 | 9,936 |
(Recovery of) provision for doubtful accounts | (118) | 40 |
Amortization of premiums and discounts on marketable securities, net | 625 | 101 |
Amortization of debt discount and issuance costs | 2,266 | 2,197 |
Deferred income tax | (346) | 0 |
Changes in assets and liabilities: | ||
Accounts receivable | 15,265 | 14,265 |
Deferred commissions | (1,059) | 603 |
Operating lease right-of-use asset | 944 | 1,098 |
Other receivables | (161) | (253) |
Prepaid expenses and other | (3,747) | (1,955) |
Other assets | (573) | (74) |
Accounts payable | 1,908 | (1,382) |
Deferred revenue | 179 | (1,228) |
Operating lease liability | (1,076) | (1,145) |
Accrued expenses and other liabilities | (7,957) | (8,021) |
Net cash provided by operating activities | 11,503 | 4,827 |
Cash flows from investing activities | ||
Purchase of property and equipment | (849) | (688) |
Purchase of marketable securities | (43,655) | (20,832) |
Sale of marketable securities | 0 | 11,423 |
Maturities of marketable securities | 40,586 | 12,975 |
Purchase of intangible assets | (71) | (77) |
Net cash (used in) provided by investing activities | (3,989) | 2,801 |
Cash flows from financing activities | ||
Proceeds from option exercises | 4,138 | 2,794 |
Taxes paid related to net share settlements of stock-based compensation awards | (7,146) | (1,379) |
Proceeds from shares issued in connection with employee stock purchase plan | 4,237 | 3,660 |
Principal payments on finance lease obligations | (417) | (398) |
Net cash provided by financing activities | 812 | 4,677 |
Effect of foreign exchange rates on cash | 16 | (613) |
Net increase in cash and cash equivalents | 8,342 | 11,692 |
Cash and cash equivalents at beginning of period | 322,831 | 381,742 |
Cash and cash equivalents at end of period | 331,173 | 393,434 |
Supplemental cash flow disclosure | ||
Cash paid for interest | 2,188 | 2,242 |
Cash paid for income taxes, net of refunds | 20 | 159 |
Supplemental disclosure of noncash investing and financing activities | ||
Allowance for tenant improvements | $ 0 | $ 124 |
Organization and Significant Ac
Organization and Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Significant Accounting Policies | Organization and Significant Accounting Policies Organization Workiva Inc., a Delaware corporation, and its wholly-owned subsidiaries (the “Company” or “we” or “us”) simplifies complex work for thousands of organizations worldwide. We are a leading provider of cloud-based compliance and regulatory reporting solutions that are designed to solve business challenges at the intersection of data, process and people. Our operational headquarters are located in Ames, Iowa, with additional offices located in the United States, Europe, the Asia-Pacific region and Canada. Basis of Presentation and Principles of Consolidation The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, the financial statements do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated balance sheet data as of December 31, 2020 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three months ended March 31, 2021 are not necessarily indicative of the results expected for the full year ending December 31, 2021. Seasonality has affected our revenue, expenses and cash flows from operations. Revenue from professional services has been higher in the first quarter as many of our customers file their Form 10-K in the first calendar quarter. Our sales and marketing expense also has some degree of seasonality. Sales and marketing expense has historically been higher in the third quarter due to our annual user conference in September. Our transition to a virtual event in September 2020 has partially mitigated this trend, and we expect marketing expenses to continue to be offset by our virtual operations through 2021. In addition, the timing of the payments of cash bonuses to employees during the first and fourth calendar quarters may result in some seasonality in operating cash flow. The condensed consolidated financial information should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report and the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed with the SEC on February 17, 2021. The unaudited condensed consolidated financial statements include the accounts of Workiva Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, the fair value of the liability and equity components of the convertible senior notes, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates. Recently Adopted Accounting Pronouncements In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which was issued to simplify the accounting for income taxes by removing certain exceptions for recognizing deferred taxes, performing intraperiod allocation, and calculating income taxes in interim periods. Further, ASU 2019-12 adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax basis goodwill and allocating taxes to members of a consolidated group. The standard became effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The standard provides different transition methods for the various provisions. Effective January 1, 2021, we adopted this standard. The adoption of this new standard did not have a material impact on our consolidated financial statements. New Accounting Pronouncements Not Yet Adopted In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity , which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share (EPS) calculations as a result of these changes. The standard will be effective for us beginning January 1, 2022 and can be applied on either a fully retrospective or modified retrospective basis. Early adoption is permitted for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of this standard on our condensed consolidated financial statements. |
Supplemental Consolidated Balan
Supplemental Consolidated Balance Sheet Information | 3 Months Ended |
Mar. 31, 2021 | |
Payables and Accruals [Abstract] | |
Supplemental Consolidated Balance Sheet Information | Supplemental Consolidated Balance Sheet Information Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of March 31, 2021 As of December 31, 2020 Accrued vacation $ 11,249 $ 10,294 Accrued commissions 6,161 12,678 Accrued bonuses 5,172 6,573 Accrued payroll 3,930 2,631 Estimated health insurance claims 1,347 1,224 Accrued interest 485 1,455 ESPP employee contributions 2,569 4,269 Customer deposits 18,604 18,283 Operating lease liabilities 4,558 4,541 Accrued other liabilities 6,035 6,308 $ 60,110 $ 68,256 |
Cash Equivalents and Marketable
Cash Equivalents and Marketable Securities | 3 Months Ended |
Mar. 31, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Cash Equivalents and Marketable Securities | Cash Equivalents and Marketable Securities At March 31, 2021, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 287,509 $ — $ — $ 287,509 Commercial paper 10,989 — — 10,989 U.S. treasury debt securities 48,502 35 (3) 48,534 Corporate debt securities 144,831 90 (81) 144,840 Foreign government debt securities 5,080 3 — 5,083 $ 496,911 $ 128 $ (84) $ 496,955 Included in cash and cash equivalents $ 287,509 $ — $ — $ 287,509 Included in marketable securities $ 209,402 $ 128 $ (84) $ 209,446 At December 31, 2020, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 265,578 $ — $ — $ 265,578 Commercial paper 21,489 — — 21,489 U.S. treasury debt securities 51,731 80 (2) 51,809 Corporate debt securities 147,715 214 (47) 147,882 Foreign government debt securities 1,025 2 — 1,027 $ 487,538 $ 296 $ (49) $ 487,785 Included in cash and cash equivalents $ 280,578 $ — $ — $ 280,578 Included in marketable securities $ 206,960 $ 296 $ (49) $ 207,207 The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of March 31, 2021 Due within one year $ 124,949 Due in on to two years 82,482 Due in three to five years 2,015 $ 209,446 The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of March 31, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of March 31, 2021 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 14,752 $ (3) $ — $ — Corporate debt securities 81,966 (81) — — Total $ 96,718 $ (84) $ — $ — We do not believe the unrealized losses represent credit losses based on our evaluation of available evidence as of March 31, 2021, which includes an assessment of whether it is more likely than not we will be required to sell the investment before recovery of the investment's amortized cost basis. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements We determine the fair values of our financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 - Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 - Inputs are unobservable inputs based on our assumptions. Financial Assets Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service. As of March 31, 2021, all of our marketable securities were valued using quoted prices for comparable instruments in active markets and are classified as Level 2. Based on our valuation of our money market funds and marketable securities, we concluded that they are classified in either Level 1 or Level 2, and we have no financial assets measured using Level 3 inputs. The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of March 31, 2021 Fair Value Measurements as of December 31, 2020 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 287,509 $ 287,509 $ — $ 265,578 $ 265,578 $ — Commercial paper 10,989 — 10,989 21,489 — 21,489 U.S. treasury debt securities 48,534 — 48,534 51,809 — 51,809 Corporate debt securities 144,840 — 144,840 147,882 — 147,882 Foreign government debt securities 5,083 — 5,083 1,027 — 1,027 $ 496,955 $ 287,509 $ 209,446 $ 487,785 $ 265,578 $ 222,207 Included in cash and cash equivalents $ 287,509 $ 280,578 Included in marketable securities $ 209,446 $ 207,207 Convertible Senior Notes As of March 31, 2021, the fair value of our convertible senior notes was $440.8 million. The fair value was determined based on the quoted price of the convertible senior notes in an over-the-counter market on the last trading day of the reporting period and has been classified as Level 2 in the fair value hierarchy. See Note 5 to the condensed consolidated financial statements for more information. |
Convertible Senior Notes
Convertible Senior Notes | 3 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Convertible Senior Notes | Convertible Senior NotesIn August 2019, we issued $345.0 million aggregate principal amount of 1.125% convertible senior notes due 2026 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, including the exercise in full by the initial purchasers of their option to purchase an additional $45.0 million principal amount (the “Notes”). The Notes were issued pursuant to an indenture and are senior, unsecured obligations of the Company. The Notes bear interest at a fixed rate of 1.125% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2020. Proceeds from the issuance of the Notes totaled $335.9 million, net of initial purchaser discounts and issuance costs. The initial conversion rate is 12.4756 shares of our common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $80.16 per share, subject to adjustment upon the occurrence of specified events. Interest expense representing the amortization of the debt discount and issuance costs as well as contractual interest expense is amortized to interest expense at an effective interest rate of 4.3% over the term of the Notes. The net carrying amount of the liability and equity components of the Notes was as follows (in thousands): March 31, 2021 December 31, 2020 Liability component: Principal $ 345,000 $ 345,000 Unamortized discount (47,331) (49,346) Unamortized issuance costs (5,913) (6,164) Net carrying amount $ 291,756 $ 289,490 Equity component, net of purchase discounts and issuance costs $ 58,560 $ 58,560 Interest expense related to the Notes is as follows (in thousands): Three months ended March 31, 2021 2020 Contractual interest expense $ 971 $ 970 Amortization of debt discount 2,015 1,953 Amortization of issuance costs 251 244 Total interest expense $ 3,237 $ 3,167 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Litigation From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We evaluate the development of legal matters on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending legal proceedings to which we are a party will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation Stock-Based Compensation Expense Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended March 31, 2021 2020 Cost of revenue Subscription and support $ 496 $ 431 Professional services 367 425 Operating expenses Research and development 2,431 1,583 Sales and marketing 3,549 2,736 General and administrative 4,780 4,761 Total $ 11,623 $ 9,936 Stock Options The following table summarizes the option activity under the Plans for the three months ended March 31, 2021: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,903,167 $ 14.48 4.7 Granted — — Forfeited (2,249) 21.55 Exercised (312,352) 13.25 Outstanding at March 31, 2021 2,588,566 $ 14.63 4.6 Exercisable at March 31, 2021 2,523,979 $ 14.48 4.5 Restricted Stock Units The following table summarizes the restricted stock unit activity under the Plan for the three months ended March 31, 2021: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2020 2,904,616 $ 35.72 Granted 614,099 100.93 Forfeited (102,474) 62.10 Vested (1) (1,178,379) 28.96 Unvested at March 31, 2021 2,237,862 $ 56.25 (1) During the three months ended March 31, 2021, in accordance with our Nonqualified Deferred Compensation Plan, recipients of 382,698 shares had elected to defer settlement of the vested restricted stock units and 6,903 shares were released from deferral. This resulted in total deferred units of 939,399 as of March 31, 2021. Employee Stock Purchase Plan During the three months ended March 31, 2021, 92,846 shares of common stock were purchased under the ESPP at a weighted-average price of $45.63 per share, resulting in cash proceeds of $4.2 million. |
Revenue Recognition
Revenue Recognition | 3 Months Ended |
Mar. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition Disaggregation of Revenue The following table presents our revenues disaggregated by industry (in thousands). Three months ended March 31, 2021 2020 Information technology $ 13,959 $ 11,090 Diversified financials 12,260 9,867 Consumer discretionary 10,977 9,437 Healthcare 10,882 8,420 Industrials 10,700 9,224 Banks 10,307 8,501 Insurance 7,073 5,941 Energy 6,831 6,424 Utilities 5,143 3,785 Real estate 4,760 4,352 Materials 4,397 3,540 Other 6,933 5,220 Total revenues $ 104,222 $ 85,801 The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended March 31, 2021 2020 Subscription and support $ 84,936 $ 68,361 XBRL professional services 14,486 13,432 Other services 4,800 4,008 Total revenues $ 104,222 $ 85,801 Deferred Revenue We recognized $79.3 million and $63.6 million of revenue during the three months ended March 31, 2021 and 2020, respectively, that was included in the deferred revenue balances at the beginning of the respective periods. Transaction Price Allocated to the Remaining Performance Obligations |
Net Loss Per Share
Net Loss Per Share | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | Net Loss Per Share Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including convertible senior notes, outstanding stock options, stock related to unvested restricted stock units, and common stock issuable pursuant to the ESPP to the extent dilutive. Basic and diluted net loss per share was the same for each period presented, as the inclusion of all potential common shares outstanding would have been anti-dilutive. The net loss per share is allocated based on the participation rights of the Class A and Class B common shares as if the loss for the year has been distributed. As the liquidation and dividend rights are identical, the net loss is allocated on a proportionate basis. A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended March 31, 2021 March 31, 2020 Class A Class B Class A Class B Numerator Net loss $ (6,161) $ (1,163) $ (8,535) $ (1,883) Denominator Weighted-average common shares outstanding - basic and diluted 42,264,288 7,979,832 38,952,305 8,593,398 Basic and diluted net loss per share $ (0.15) $ (0.15) $ (0.22) $ (0.22) The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of March 31, 2021 March 31, 2020 Shares subject to outstanding common stock options 2,588,566 4,106,122 Shares subject to unvested restricted stock units 2,237,862 3,335,671 Shares issuable pursuant to the ESPP 59,359 107,331 |
Organization and Significant _2
Organization and Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, the financial statements do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated balance sheet data as of December 31, 2020 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three months ended March 31, 2021 are not necessarily indicative of the results expected for the full year ending December 31, 2021. |
Principles of Consolidation | All intercompany accounts and transactions have been eliminated in consolidation. |
Use of Estimates | The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, the fair value of the liability and equity components of the convertible senior notes, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates. |
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Not Yet Adopted | In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which was issued to simplify the accounting for income taxes by removing certain exceptions for recognizing deferred taxes, performing intraperiod allocation, and calculating income taxes in interim periods. Further, ASU 2019-12 adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax basis goodwill and allocating taxes to members of a consolidated group. The standard became effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The standard provides different transition methods for the various provisions. Effective January 1, 2021, we adopted this standard. The adoption of this new standard did not have a material impact on our consolidated financial statements. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity , which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share (EPS) calculations as a result of these changes. The standard will be effective for us beginning January 1, 2022 and can be applied on either a fully retrospective or modified retrospective basis. Early adoption is permitted for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of this standard on our condensed consolidated financial statements. |
Fair Value of Financial Instruments | Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service. |
Supplemental Consolidated Bal_2
Supplemental Consolidated Balance Sheet Information (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Payables and Accruals [Abstract] | |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (in thousands): As of March 31, 2021 As of December 31, 2020 Accrued vacation $ 11,249 $ 10,294 Accrued commissions 6,161 12,678 Accrued bonuses 5,172 6,573 Accrued payroll 3,930 2,631 Estimated health insurance claims 1,347 1,224 Accrued interest 485 1,455 ESPP employee contributions 2,569 4,269 Customer deposits 18,604 18,283 Operating lease liabilities 4,558 4,541 Accrued other liabilities 6,035 6,308 $ 60,110 $ 68,256 |
Cash Equivalents and Marketab_2
Cash Equivalents and Marketable Securities (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Marketable Securities | At March 31, 2021, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 287,509 $ — $ — $ 287,509 Commercial paper 10,989 — — 10,989 U.S. treasury debt securities 48,502 35 (3) 48,534 Corporate debt securities 144,831 90 (81) 144,840 Foreign government debt securities 5,080 3 — 5,083 $ 496,911 $ 128 $ (84) $ 496,955 Included in cash and cash equivalents $ 287,509 $ — $ — $ 287,509 Included in marketable securities $ 209,402 $ 128 $ (84) $ 209,446 At December 31, 2020, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 265,578 $ — $ — $ 265,578 Commercial paper 21,489 — — 21,489 U.S. treasury debt securities 51,731 80 (2) 51,809 Corporate debt securities 147,715 214 (47) 147,882 Foreign government debt securities 1,025 2 — 1,027 $ 487,538 $ 296 $ (49) $ 487,785 Included in cash and cash equivalents $ 280,578 $ — $ — $ 280,578 Included in marketable securities $ 206,960 $ 296 $ (49) $ 207,207 |
Schedule of Cash and Cash Equivalents | At March 31, 2021, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 287,509 $ — $ — $ 287,509 Commercial paper 10,989 — — 10,989 U.S. treasury debt securities 48,502 35 (3) 48,534 Corporate debt securities 144,831 90 (81) 144,840 Foreign government debt securities 5,080 3 — 5,083 $ 496,911 $ 128 $ (84) $ 496,955 Included in cash and cash equivalents $ 287,509 $ — $ — $ 287,509 Included in marketable securities $ 209,402 $ 128 $ (84) $ 209,446 At December 31, 2020, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 265,578 $ — $ — $ 265,578 Commercial paper 21,489 — — 21,489 U.S. treasury debt securities 51,731 80 (2) 51,809 Corporate debt securities 147,715 214 (47) 147,882 Foreign government debt securities 1,025 2 — 1,027 $ 487,538 $ 296 $ (49) $ 487,785 Included in cash and cash equivalents $ 280,578 $ — $ — $ 280,578 Included in marketable securities $ 206,960 $ 296 $ (49) $ 207,207 |
Summary of Investments Classified by Contractual Maturity Date | The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of March 31, 2021 Due within one year $ 124,949 Due in on to two years 82,482 Due in three to five years 2,015 $ 209,446 |
Schedule of Available-for-sale Securities, Continuous Unrealized Loss Position | The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of March 31, 2021, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of March 31, 2021 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 14,752 $ (3) $ — $ — Corporate debt securities 81,966 (81) — — Total $ 96,718 $ (84) $ — $ — |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets Measured on Recurring Basis | The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of March 31, 2021 Fair Value Measurements as of December 31, 2020 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 287,509 $ 287,509 $ — $ 265,578 $ 265,578 $ — Commercial paper 10,989 — 10,989 21,489 — 21,489 U.S. treasury debt securities 48,534 — 48,534 51,809 — 51,809 Corporate debt securities 144,840 — 144,840 147,882 — 147,882 Foreign government debt securities 5,083 — 5,083 1,027 — 1,027 $ 496,955 $ 287,509 $ 209,446 $ 487,785 $ 265,578 $ 222,207 Included in cash and cash equivalents $ 287,509 $ 280,578 Included in marketable securities $ 209,446 $ 207,207 |
Convertible Senior Notes (Table
Convertible Senior Notes (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Summary of Convertible Debt | The net carrying amount of the liability and equity components of the Notes was as follows (in thousands): March 31, 2021 December 31, 2020 Liability component: Principal $ 345,000 $ 345,000 Unamortized discount (47,331) (49,346) Unamortized issuance costs (5,913) (6,164) Net carrying amount $ 291,756 $ 289,490 Equity component, net of purchase discounts and issuance costs $ 58,560 $ 58,560 Interest expense related to the Notes is as follows (in thousands): Three months ended March 31, 2021 2020 Contractual interest expense $ 971 $ 970 Amortization of debt discount 2,015 1,953 Amortization of issuance costs 251 244 Total interest expense $ 3,237 $ 3,167 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Stock-based Compensation Expense | Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended March 31, 2021 2020 Cost of revenue Subscription and support $ 496 $ 431 Professional services 367 425 Operating expenses Research and development 2,431 1,583 Sales and marketing 3,549 2,736 General and administrative 4,780 4,761 Total $ 11,623 $ 9,936 |
Schedule of Stock-Option Activity | The following table summarizes the option activity under the Plans for the three months ended March 31, 2021: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,903,167 $ 14.48 4.7 Granted — — Forfeited (2,249) 21.55 Exercised (312,352) 13.25 Outstanding at March 31, 2021 2,588,566 $ 14.63 4.6 Exercisable at March 31, 2021 2,523,979 $ 14.48 4.5 |
Summary of Restricted Stock Units | The following table summarizes the restricted stock unit activity under the Plan for the three months ended March 31, 2021: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2020 2,904,616 $ 35.72 Granted 614,099 100.93 Forfeited (102,474) 62.10 Vested (1) (1,178,379) 28.96 Unvested at March 31, 2021 2,237,862 $ 56.25 |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table presents our revenues disaggregated by industry (in thousands). Three months ended March 31, 2021 2020 Information technology $ 13,959 $ 11,090 Diversified financials 12,260 9,867 Consumer discretionary 10,977 9,437 Healthcare 10,882 8,420 Industrials 10,700 9,224 Banks 10,307 8,501 Insurance 7,073 5,941 Energy 6,831 6,424 Utilities 5,143 3,785 Real estate 4,760 4,352 Materials 4,397 3,540 Other 6,933 5,220 Total revenues $ 104,222 $ 85,801 The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended March 31, 2021 2020 Subscription and support $ 84,936 $ 68,361 XBRL professional services 14,486 13,432 Other services 4,800 4,008 Total revenues $ 104,222 $ 85,801 |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended March 31, 2021 March 31, 2020 Class A Class B Class A Class B Numerator Net loss $ (6,161) $ (1,163) $ (8,535) $ (1,883) Denominator Weighted-average common shares outstanding - basic and diluted 42,264,288 7,979,832 38,952,305 8,593,398 Basic and diluted net loss per share $ (0.15) $ (0.15) $ (0.22) $ (0.22) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of March 31, 2021 March 31, 2020 Shares subject to outstanding common stock options 2,588,566 4,106,122 Shares subject to unvested restricted stock units 2,237,862 3,335,671 Shares issuable pursuant to the ESPP 59,359 107,331 |
Supplemental Consolidated Bal_3
Supplemental Consolidated Balance Sheet Information - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Accrued Liabilities and Other Liabilities [Abstract] | ||
Accrued vacation | $ 11,249 | $ 10,294 |
Accrued commissions | 6,161 | 12,678 |
Accrued bonuses | 5,172 | 6,573 |
Accrued payroll | 3,930 | 2,631 |
Estimated health insurance claims | 1,347 | 1,224 |
Accrued interest | 485 | 1,455 |
ESPP employee contributions | 2,569 | 4,269 |
Customer deposits | 18,604 | 18,283 |
Operating lease liabilities | 4,558 | 4,541 |
Accrued other liabilities | 6,035 | 6,308 |
Accrued expenses and other current liabilities | $ 60,110 | $ 68,256 |
Cash Equivalents and Marketab_3
Cash Equivalents and Marketable Securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | $ 331,173 | $ 322,831 |
Debt Securities, Available-for-sale [Line Items] | ||
Unrealized Gains | 128 | 296 |
Unrealized Losses | (84) | (49) |
Aggregate Fair Value | 209,446 | |
Cash and cash equivalents and available-for-sale securities, amortized cost | 496,911 | 487,538 |
Cash, cash equivalents, and available-for-sale securities | 496,955 | 487,785 |
Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 10,989 | 21,489 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Aggregate Fair Value | 10,989 | 21,489 |
U.S. treasury debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 48,502 | 51,731 |
Unrealized Gains | 35 | 80 |
Unrealized Losses | (3) | (2) |
Aggregate Fair Value | 48,534 | 51,809 |
Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 144,831 | 147,715 |
Unrealized Gains | 90 | 214 |
Unrealized Losses | (81) | (47) |
Aggregate Fair Value | 144,840 | 147,882 |
Foreign government debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 5,080 | 1,025 |
Unrealized Gains | 3 | 2 |
Unrealized Losses | 0 | 0 |
Aggregate Fair Value | 5,083 | 1,027 |
Money market funds | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | 287,509 | 265,578 |
Cash and cash equivalents, aggregate fair value | 287,509 | 265,578 |
Cash and cash equivalents | ||
Cash and Cash Equivalents [Line Items] | ||
Cash and cash equivalents | 287,509 | 280,578 |
Cash and cash equivalents, aggregate fair value | 287,509 | 280,578 |
Marketable securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 209,402 | 206,960 |
Unrealized Gains | 128 | 296 |
Unrealized Losses | (84) | (49) |
Aggregate Fair Value | $ 209,446 | $ 207,207 |
Cash Equivalents and Marketab_4
Cash Equivalents and Marketable Securities - Schedule of Contractual Maturities (Details) $ in Thousands | Mar. 31, 2021USD ($) |
Investments, Debt and Equity Securities [Abstract] | |
Due within one year | $ 124,949 |
Due in on to two years | 82,482 |
Due in three to five years | 2,015 |
Marketable securities | $ 209,446 |
Cash Equivalents and Marketab_5
Cash Equivalents and Marketable Securities - Continuous Unrealized Loss Position (Details) $ in Thousands | Mar. 31, 2021USD ($) |
Fair Value | |
Less than 12 months | $ 96,718 |
12 months or greater | 0 |
Unrealized Loss | |
Less than 12 months | (84) |
12 months or greater | 0 |
U.S. treasury debt securities | |
Fair Value | |
Less than 12 months | 14,752 |
12 months or greater | 0 |
Unrealized Loss | |
Less than 12 months | (3) |
12 months or greater | 0 |
Corporate debt securities | |
Fair Value | |
Less than 12 months | 81,966 |
12 months or greater | 0 |
Unrealized Loss | |
Less than 12 months | (81) |
12 months or greater | $ 0 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | $ 209,446 | |
Cash and cash equivalents | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents - money market funds | 287,509 | $ 280,578 |
Marketable securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 209,446 | 207,207 |
Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 10,989 | 21,489 |
U.S. treasury debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 48,534 | 51,809 |
Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 144,840 | 147,882 |
Foreign government debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 5,083 | 1,027 |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents - money market funds | 287,509 | 265,578 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of convertible debt | 440,800 | |
Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | 496,955 | 487,785 |
Recurring | Cash and cash equivalents | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents - money market funds | 287,509 | 280,578 |
Recurring | Marketable securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 209,446 | 207,207 |
Recurring | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 10,989 | 21,489 |
Recurring | U.S. treasury debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 48,534 | 51,809 |
Recurring | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 144,840 | 147,882 |
Recurring | Foreign government debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 5,083 | 1,027 |
Recurring | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents - money market funds | 287,509 | 265,578 |
Recurring | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | 287,509 | 265,578 |
Recurring | Level 1 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Recurring | Level 1 | U.S. treasury debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Recurring | Level 1 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Recurring | Level 1 | Foreign government debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Recurring | Level 1 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents - money market funds | 287,509 | 265,578 |
Recurring | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | 209,446 | 222,207 |
Recurring | Level 2 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 10,989 | 21,489 |
Recurring | Level 2 | U.S. treasury debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 48,534 | 51,809 |
Recurring | Level 2 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 144,840 | 147,882 |
Recurring | Level 2 | Foreign government debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 5,083 | 1,027 |
Recurring | Level 2 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents - money market funds | $ 0 | $ 0 |
Convertible Senior Notes (Detai
Convertible Senior Notes (Details) - Convertible debt | 1 Months Ended |
Aug. 31, 2019USD ($)$ / shares | |
1.125% Convertible Senior Notes Due 2026 | |
Debt Instrument [Line Items] | |
Face amount of debt issued | $ 345,000,000 |
Stated interest percentage | 1.125% |
Proceeds from the issuance of convertible senior notes, net of issuance costs | $ 335,900,000 |
Conversion ratio | 0.0124756 |
Conversion price (in dollars per share) | $ / shares | $ 80.16 |
Effective interest percentage | 4.30% |
Over-allotment option | |
Debt Instrument [Line Items] | |
Face amount of debt issued | $ 45,000,000 |
Convertible Senior Notes - Summ
Convertible Senior Notes - Summary of Convertible Debt (Details) - 1.125% Convertible Senior Notes Due 2026 - Convertible debt - USD ($) $ in Thousands | Mar. 31, 2021 | Dec. 31, 2020 |
Debt Instrument [Line Items] | ||
Principal | $ 345,000 | $ 345,000 |
Unamortized discount | (47,331) | (49,346) |
Unamortized issuance costs | (5,913) | (6,164) |
Net carrying amount | 291,756 | 289,490 |
Equity component, net of purchase discounts and issuance costs | $ 58,560 | $ 58,560 |
Convertible Senior Notes - Su_2
Convertible Senior Notes - Summary of Interest Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Debt Disclosure [Abstract] | ||
Contractual interest expense | $ 971 | $ 970 |
Amortization of debt discount | 2,015 | 1,953 |
Amortization of issuance costs | 251 | 244 |
Total interest expense | $ 3,237 | $ 3,167 |
Stock-Based Compensation - Expe
Stock-Based Compensation - Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | $ 11,623 | $ 9,936 |
Research and development | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 2,431 | 1,583 |
Sales and marketing | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 3,549 | 2,736 |
General and administrative | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 4,780 | 4,761 |
Subscription and support | Cost of revenue | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | 496 | 431 |
Professional services | Cost of revenue | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | $ 367 | $ 425 |
Stock-Based Compensation - Stoc
Stock-Based Compensation - Stock Options (Details) - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2021 | Dec. 31, 2020 | |
Options (in shares): | ||
Outstanding beginning of the period (in shares) | 2,903,167 | |
Granted (in shares) | 0 | |
Forfeited (in shares) | (2,249) | |
Exercised (in shares) | (312,352) | |
Outstanding end of the period (in shares) | 2,588,566 | 2,903,167 |
Exercisable (in shares) | 2,523,979 | |
Weighted-Average Exercise Price (in dollars per share): | ||
Outstanding beginning of the period (in dollars per share) | $ 14.48 | |
Granted (in dollars per share) | 0 | |
Forfeited (in dollars per share) | 21.55 | |
Exercised (in dollars per share) | 13.25 | |
Outstanding end of the period (in dollars per share) | 14.63 | $ 14.48 |
Exercisable (in dollars per share) | $ 14.48 | |
Outstanding, weighted-average remaining contractual term (years) | 4 years 7 months 6 days | 4 years 8 months 12 days |
Exercisable, weighted-average remaining contractual term (years) | 4 years 6 months |
Stock-Based Compensation - Rest
Stock-Based Compensation - Restricted Stock Units (Details) - Restricted stock units | 3 Months Ended |
Mar. 31, 2021$ / sharesshares | |
Number of Shares (in shares) | |
Unvested at beginning of period (in shares) | 2,904,616 |
Granted (in shares) | 614,099 |
Forfeited (in shares) | (102,474) |
Vested (in shares) | (1,178,379) |
Unvested at end of period (in shares) | 2,237,862 |
Weighted- Average Grant Date Fair Value (in dollars per share) | |
Unvested at beginning of period (in dollars per share) | $ / shares | $ 35.72 |
Granted (in dollars per share) | $ / shares | 100.93 |
Forfeited (in dollars per share) | $ / shares | 62.10 |
Vested (in dollars per share) | $ / shares | 28.96 |
Unvested at end of period (in dollars per share) | $ / shares | $ 56.25 |
Number of vested shares recipient elected to defer settlement (in shares) | 382,698 |
Number of vested shares recipients elected to defer settlement, released during period (in shares) | 6,903 |
Number of deferred shares vested and outstanding (in shares) | 939,399 |
Stock-Based Compensation - Empl
Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Proceeds from shares issued in connection with employee stock purchase plan | $ 4,237 | $ 3,660 |
Employee Stock Purchase Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized compensation expense | $ 930 | |
Unrecognized compensation expense, period for recognition (years) | 3 months 18 days | |
Class A Common Stock | Employee Stock Purchase Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares issued during period (in shares) | 92,846 | |
Shares issued during period, weighted average price per share (in dollars per share) | $ 45.63 | |
Proceeds from shares issued in connection with employee stock purchase plan | $ 4,200 |
Revenue Recognition - Disaggreg
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 104,222 | $ 85,801 |
Subscription and support | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 84,936 | 68,361 |
XBRL professional services | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 14,486 | 13,432 |
Other services | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 4,800 | 4,008 |
Information technology | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 13,959 | 11,090 |
Diversified financials | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 12,260 | 9,867 |
Consumer discretionary | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 10,977 | 9,437 |
Healthcare | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 10,882 | 8,420 |
Industrials | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 10,700 | 9,224 |
Banks | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 10,307 | 8,501 |
Insurance | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 7,073 | 5,941 |
Energy | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 6,831 | 6,424 |
Utilities | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 5,143 | 3,785 |
Real estate | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 4,760 | 4,352 |
Materials | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 4,397 | 3,540 |
Other | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 6,933 | $ 5,220 |
Revenue Recognition - Deferred
Revenue Recognition - Deferred Revenue and Transaction Price Allocated to the Remaining Performance Obligations (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Revenue from Contract with Customer [Abstract] | ||
Deferred revenue recognized | $ 79.3 | $ 63.6 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue expected to be recognized | 421 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-04-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue expected to be recognized | $ 259.3 | |
Expected period of recognition | 24 months |
Net Loss Per Share - Earnings P
Net Loss Per Share - Earnings Per Share Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Denominator | ||
Weighted-average common shares outstanding - basic | 50,244,120 | 47,545,703 |
Weighted-average common shares outstanding - diluted | 50,244,120 | 47,545,703 |
Basic net loss per share (in dollars per share) | $ (0.15) | $ (0.22) |
Diluted net loss per share (in dollars per share) | $ (0.15) | $ (0.22) |
Class A Common Stock | ||
Numerator | ||
Net loss | $ (6,161) | $ (8,535) |
Net loss | $ (6,161) | $ (8,535) |
Denominator | ||
Weighted-average common shares outstanding - basic | 42,264,288 | 38,952,305 |
Weighted-average common shares outstanding - diluted | 42,264,288 | 38,952,305 |
Basic net loss per share (in dollars per share) | $ (0.15) | $ (0.22) |
Diluted net loss per share (in dollars per share) | $ (0.15) | $ (0.22) |
Class B Common Stock | ||
Numerator | ||
Net loss | $ (1,163) | $ (1,883) |
Net loss | $ (1,163) | $ (1,883) |
Denominator | ||
Weighted-average common shares outstanding - basic | 7,979,832 | 8,593,398 |
Weighted-average common shares outstanding - diluted | 7,979,832 | 8,593,398 |
Basic net loss per share (in dollars per share) | $ (0.15) | $ (0.22) |
Diluted net loss per share (in dollars per share) | $ (0.15) | $ (0.22) |
Net Loss Per Share - Antidiluti
Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Class A Common Stock | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 4,300,000 | |
Shares subject to outstanding common stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 2,588,566 | 4,106,122 |
Shares subject to unvested restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 2,237,862 | 3,335,671 |
Shares issuable pursuant to the ESPP | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 59,359 | 107,331 |